Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.

NCT03933930 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.

NCT NCT03933930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03933930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
Lead sponsor
Taipei Medical University WanFang Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
May 6, 2019
Completion date
May 15, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

organ failure, multiple